Eric Swayze insider trades: Ionis Pharmaceuticals (IONS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | IONS | ↓ Sell | 53 | $43.54 | $2K | by Son | Oct 19, 2026 (3d) |
| Feb 13, 2026 | IONS | ↓ Sell10b5-1 | 15,642 | $81.76 | $1.3M | Direct | Feb 13, 2026 (0d) |
| Jan 30, 2026 | IONS | ↓ Sell | 6,179 | $82.93 | $512K | Direct | Feb 2, 2026 (3d) |
| Jan 16, 2026 | IONS | ↓ Sell | 9,884 | $75.34 | $745K | Direct | Jan 20, 2026 (4d) |
| Jan 16, 2026 | IONS | ↓ Sell | 49 | $75.97 | $4K | by Son | Jan 20, 2026 (4d) |
| Jan 2, 2026 | IONS | ↓ Sell10b5-1 | 23,463 | $79.12 | $1.9M | Direct | Jan 6, 2026 (4d) |
| Oct 16, 2025 | IONS | ↓ Sell | 53 | $73.62 | $4K | by Son | Oct 16, 2025 (0d) |
| Oct 6, 2025 | IONS | ↓ Sell10b5-1 | 6,849 | $69.02 | $473K | Direct | Oct 8, 2025 (2d) |
| Oct 2, 2025 | IONS | ↓ Sell10b5-1 | 27,114 | $66.16 | $1.8M | Direct | Oct 2, 2025 (0d) |
| Sep 2, 2025 | IONS | ↓ Sell10b5-1 | 11,130 | $49.67 | $553K | Direct | Sep 4, 2025 (2d) |
| Jan 31, 2025 | IONS | ↓ Sell | 1,367 | $32.31 | $44K | Direct | Feb 3, 2025 (3d) |
| Jan 16, 2025 | IONS | ↓ Sell | 7,154 | $32.84 | $235K | Direct | Jan 17, 2025 (1d) |
| Jan 16, 2025 | IONS | ↓ Sell | 22 | $32.70 | $719 | by Son | Jan 17, 2025 (1d) |
| Nov 12, 2024 | IONS | ↓ Sell10b5-1 | 1,194 | $37.92 | $45K | Direct | Nov 14, 2024 (2d) |
| Oct 16, 2024 | IONS | ↓ Sell | 53 | $38.31 | $2K | by Son | Oct 17, 2024 (1d) |
| Feb 2, 2024 | IONS | ↓ Sell | 12,680 | $51.63 | $655K | Direct | Feb 2, 2024 (0d) |
| Jan 17, 2024 | IONS | ↓ Sell | 6,296 | $50.42 | $317K | Direct | Jan 18, 2024 (1d) |
| Jan 17, 2024 | IONS | ↓ Sell | 9 | $50.42 | $454 | by Son | Jan 18, 2024 (1d) |
| Dec 28, 2023 | IONS | ↓ Sell | 27,100 | $50.19 | $1.4M | Direct | Jan 2, 2024 (5d) |
| Oct 17, 2023 | IONS | ↓ Sell | 52 | $47.95 | $2K | by Son | Oct 18, 2023 (1d) |
| Feb 6, 2023 | IONS | ↓ Sell | 1,815 | $40.79 | $74K | Direct | Feb 7, 2023 (1d) |
| Jan 18, 2023 | IONS | ↓ Sell | 5,631 | $39.74 | $224K | Direct | Jan 19, 2023 (1d) |
| Sep 8, 2022 | IONS | ↓ Sell10b5-1 | 460 | $44.55 | $20K | Direct | Sep 12, 2022 (4d) |
| Aug 5, 2022 | IONS | ↓ Sell10b5-1 | 1 | $45.20 | $45 | Direct | Aug 9, 2022 (4d) |
| Apr 21, 2022 | IONS | ↓ Sell10b5-1 | 378 | $44.15 | $17K | Direct | Apr 25, 2022 (4d) |
| Jan 5, 2021 | IONS | ↓ Sell10b5-1 | 195 | $55.99 | $11K | Direct | Jan 6, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IONS insiders
Open-market trades in the last 12 months
About Eric Swayze's insider trades
Eric Swayze is EVP Research at Ionis Pharmaceuticals (IONS). Since Jan 5, 2021, Eric has reported no open-market purchases and 26 sales worth $10.2M on SEC Form 4. In the last 12 months: 6 sales ($4.4M).
10 sales (59% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (20 filings), option exercises (14 filings), other transactions (9 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IONS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.